Testing the Bradycardiac Effect of Newly Synthesized Potential Ultrashort Beta-
-Blockers on the Laboratory Rat
BARTOŠOVÁ L., FRYDRYCH M., MOKRÝ P.1, BRUNCLÍK V.2, BAHNÍKOVÁ M.3
Ústav humánní farmakologie a toxikologie Farmaceutické fakulty Veterinární a farmaceutické univerzity, Brno 1Ústav chemických léčiv Farmaceutické fakulty Veterinární a farmaceutické univerzity, Brno 2Klinika malých zvířat Fakulty veterinárního lékařství Veterinární a farmaceutické univerzity, Brno 3Fyziologický ústav Lékařské fakulty Masarykovy univerzity, Brno |
|
Summary:
With the use of normotensive laboratory Wistar strain rats, changes in heart rate induced by three
newly synthesized potential ultrashort beta-blockers were tested. The animals were administered
the tested substances intravenously in general anesthesia. In all animals, heart rate was measured
at predetermined time intervals. All obtained values were converted into the per cents of the heart
rate deviation and the results were statistically processed. Using F-test, variability of dispersion
was determined, and using Student t-test, statistical significance of the particular change was
determined. In all three substances tested, a statistically demonstrable short-time bradycardiac
effect was observed. The most marked decrease took place in the first minute after intravenous
administration. Substance 44Bu induced the significantly deepest decrease in heart rate (by
13.00%), which lasted longest. No statistically significant difference was found between the actions
of substances 42Bu and 43Bu. In all three substances tested, marked changes in the ECG record
were observed immediately after intravenous administration. PQ and QT intervals and QRS
complex were prolonged, and marked S wave, elevation of the T wave, and a decrease in R wave
occurred. The changes were accompanied by a change in the electric cardiac axis.
Key words:
ultrashort-acting beta-blockers – heart rate – changes in ECG – ion channels
|